Sourcing · Regulatory

Import rules for personal quantities, by jurisdiction, dated

Sourcing › Regulatory compounding MHRA FDA personal import

m.duarteTL228 Mar 2025#1

On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion.

I was wrong about import rules for personal quantities in a thread last spring and I would like to correct it publicly rather than quietly.

The error was in the units, which changed the conclusion by an order of magnitude. Setting out the corrected version, and the way I now check for that class of mistake.

0 likes 16mo

f.novakTL215 May 2025#2

Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal use depends on your country's rules, not on where it is sold.

Someone should write this up properly, and it should probably not be me.

0 likes 14mo

buffer_reviewTL3Regular19 Jun 2025#3

Post #2 answers the question as asked. The question underneath it is different.

Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict and vary by jurisdiction. Generalising from one country's rules to another's is unreliable.

Take it as a starting point and not as a specification.

4 likes 13mo

a.norgaardTL219 Jul 2025#4

Import rules for personal quantities differ from commercial import rules and both differ by country. Establishing your own position is not something a forum can do for you.

One more caveat and then I will stop qualifying: the sample selected itself.

12 likes 12mo

This topic was referenced in

What a regulator's shortage notice actually authorisesSourcing › Regulatory · 12 replies
Labelling requirements for research chemicalsSourcing › Regulatory · 9 replies
Enforcement priorities versus written rules — does this still hold?Sourcing › Regulatory · 40 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Enforcement priorities versus written rules — does this still hold? Sourcing › Regulatory EMA MHRA compounding FDA Solved Under review Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says,…	+36	40	37k	11mo
Pharmaceutical compounding rules, summarised from primary sources Sourcing › Regulatory MHRA EMA research use only Closed Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…	+135	163	46k	17mo
Research-use-only labelling: what it means and what it does not Sourcing › Regulatory compounding research use only EMA FDA Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling question, and I would like the answer to be…	+100	110	37k	5mo
How compounding permissions changed when supply normalised Sourcing › Regulatory personal import EMA compounding research use only Solved Asking directly, because I could not find a straight answer: How compounding permissions changed when supply normalised I was wrong about compounding permissions in a thread last spring and I would like to…	+30	34	51k	16mo
Prescription requirements and telehealth models Sourcing › Regulatory FDA compounding research use only MHRA Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. Proposing that prescription requirements and telehealth models deserves a…	+91	97	5.4k	7mo

Related topics — sharing the tags compounding, MHRA, FDA

Topic	Participants	Replies	Views	Activity
Official shortage notices and what they authorise Access › Shortages compounding formulary shortage Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Trying to work out what would count as evidence on official shortage…	+106	119	18k	1mo
MHRA statements, read directly Regional › UK & Ireland NHS MHRA personal import Solved Pinned MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have read four threads on it and each…	+93	101	2.2k	5mo
NHS criteria and how they are applied in practice Regional › UK & Ireland NHS cost per milligram personal import MHRA NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…	+37	42	31k	2d
Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA MHRA research use only EMA Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…	+72	78	23k	3mo
List price versus negotiated price versus what you pay Access › Pricing formulary data table compounding Under review On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. List price versus negotiated price — I have the observation and I do not trust my…	+99	115	11k	3mo

Sponsored PeptideMeter — peptide analytics and supplier verificationPurity analysis and structured supplier verification, published as dated records rather than scores. Referenced throughout our sourcing documentation.View analytics →